In the inflammatory immune microenvironment, increased interferon (IFN) γ release due to increased CTL infiltration induces programmed cell death-ligand 1 (PD-L1) expression on tumor and stromal cells and is therefore sensitive to immune checkpoint inhibitors (ICIs) therapy [26]. The gene discussed is CD274; the disease is neoplasm.